nav mail map-pin
AIMM Therapeutics

AIMM Therapeutics

Our companies AIMM Therapeutics

AIMM Therapeutics

AIMM is a biotech company spun-out of the Netherlands Cancer Institute and the Academic Medical Center at the University of Amsterdam. The company aims to develop high quality human monoclonal antibodies to treat diseases with a high, unmet medical need. AIMM exploits and develops new, innovative technologies to generate stable monoclonal cell lines of human antibody-producing B cells against infectious agents.

Visit website
Contact: Tom Schwarz
Back to our companies
AIMM Therapeutics